Same Indication

Ipilimumab vs Metoprolol

Ipilimumab vs Metoprolol: Overview

This comparison examines the pharmacological differences between Ipilimumab and Metoprolol.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Metoprolol: Selective beta-1 adrenergic receptor blocker.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Metoprolol — 3-7 hours.

Chemical Properties

Molecular Formula: Metoprolol — C15H25NO3.

Molecular Weight: Metoprolol — 267.3640 g/mol.

Type: Ipilimumab — Antibody; Metoprolol — Small molecule.